Diğdem Yöyen-Ermiş

588 total citations
23 papers, 417 citations indexed

About

Diğdem Yöyen-Ermiş is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Diğdem Yöyen-Ermiş has authored 23 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Diğdem Yöyen-Ermiş's work include Immune Cell Function and Interaction (7 papers), Immune cells in cancer (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Diğdem Yöyen-Ermiş is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immune cells in cancer (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Diğdem Yöyen-Ermiş collaborates with scholars based in Türkiye, France and Austria. Diğdem Yöyen-Ermiş's co-authors include Güneş Esendağlı, Utku Horzum, Ece Tavukçuoğlu, Didem Özkazanç, Yahya Büyükaşık, Seçil Çaban, Yılmaz Çapan, Patrick Couvreur, Adem Şahin and Yeşim Aktaş and has published in prestigious journals such as PLoS ONE, Scientific Reports and European Journal of Immunology.

In The Last Decade

Diğdem Yöyen-Ermiş

22 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diğdem Yöyen-Ermiş Türkiye 12 140 123 118 110 60 23 417
Ece Tavukçuoğlu Türkiye 16 176 1.3× 169 1.4× 161 1.4× 124 1.1× 45 0.8× 26 505
Hannah L. O’Mary United States 9 200 1.4× 251 2.0× 75 0.6× 150 1.4× 57 0.9× 10 564
Nathan A. Rohner United States 12 225 1.6× 169 1.4× 197 1.7× 115 1.0× 51 0.8× 23 573
Dipak S. Pisal United States 8 68 0.5× 342 2.8× 42 0.4× 153 1.4× 96 1.6× 12 600
Luisa Vicari Italy 15 49 0.3× 285 2.3× 141 1.2× 83 0.8× 77 1.3× 22 557
Parvin Mahdipoor Canada 14 42 0.3× 396 3.2× 76 0.6× 143 1.3× 49 0.8× 22 601
Christian A. Fernandez United States 16 86 0.6× 318 2.6× 82 0.7× 131 1.2× 12 0.2× 33 725
Scott Poh United States 11 62 0.4× 115 0.9× 54 0.5× 110 1.0× 34 0.6× 15 427
Kaiqing Yun China 9 100 0.7× 84 0.7× 42 0.4× 107 1.0× 35 0.6× 14 366
Joseph Piscitelli United States 9 65 0.5× 126 1.0× 113 1.0× 95 0.9× 38 0.6× 19 365

Countries citing papers authored by Diğdem Yöyen-Ermiş

Since Specialization
Citations

This map shows the geographic impact of Diğdem Yöyen-Ermiş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diğdem Yöyen-Ermiş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diğdem Yöyen-Ermiş more than expected).

Fields of papers citing papers by Diğdem Yöyen-Ermiş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diğdem Yöyen-Ermiş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diğdem Yöyen-Ermiş. The network helps show where Diğdem Yöyen-Ermiş may publish in the future.

Co-authorship network of co-authors of Diğdem Yöyen-Ermiş

This figure shows the co-authorship network connecting the top 25 collaborators of Diğdem Yöyen-Ermiş. A scholar is included among the top collaborators of Diğdem Yöyen-Ermiş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diğdem Yöyen-Ermiş. Diğdem Yöyen-Ermiş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yöyen-Ermiş, Diğdem, et al.. (2025). Effects of Uridine and Uridine Nucleotides on Proliferation and Migration of L929 Murine Fibroblast Cell Line. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 51(1). 105–110.
3.
Horzum, Utku, M. Alper Kursunel, Diğdem Yöyen-Ermiş, et al.. (2023). Liver resection modulates hepatic chemokine levels in breast cancer. Surgery. 174(2). 277–282. 1 indexed citations
4.
5.
Yöyen-Ermiş, Diğdem, et al.. (2023). Pro-fibrogenic and adipogenic aspects of chronic muscle degeneration are contributed by distinct stromal cell subpopulations. PLoS ONE. 18(7). e0288800–e0288800. 3 indexed citations
6.
Çağan, Eren, Gülçin Tezcan, Ali Aşan, et al.. (2022). The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis. Viral Immunology. 35(4). 318–327. 7 indexed citations
7.
Çağan, Eren, Gülçin Tezcan, Ali Aşan, et al.. (2022). Assessment of CD39 expression in regulatory T‐cell subsets by disease severity in adult and juvenile COVID‐19 cases. Journal of Medical Virology. 94(5). 2089–2101. 12 indexed citations
8.
Ursavaş, Ahmet, Aslı Görek Dilektaşlı, Funda Çoşkun, et al.. (2021). Interleukin-21: a potential biomarker for diagnosis and predicting prognosis in COVID-19 patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2274–2284. 6 indexed citations
9.
Horzum, Utku, Diğdem Yöyen-Ermiş, Ekim Z. Taşkıran, et al.. (2020). CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer. Cancer Immunology Immunotherapy. 70(1). 75–87. 18 indexed citations
10.
Ünver, Neşe, et al.. (2020). Transcriptional splice variants of CD40 and its prognostic value in breast cancer. TURKISH JOURNAL OF BIOLOGY. 44(2). 73–81. 6 indexed citations
11.
Tavukçuoğlu, Ece, Utku Horzum, Hamdullah Yanık, et al.. (2020). Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer. European Journal of Immunology. 50(12). 2067–2074. 36 indexed citations
12.
Akkaya‐Ulum, Yeliz Z., et al.. (2019). A method for high-purity isolation of neutrophil granulocytes for functional cell migration assays. Turkish Journal of Biochemistry. 44(6). 810–821. 5 indexed citations
13.
Yöyen-Ermiş, Diğdem, Ece Tavukçuoğlu, Utku Horzum, et al.. (2019). Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS. Scientific Reports. 9(1). 11697–11697. 46 indexed citations
14.
Timur, Selin Seda, et al.. (2019). Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer. European Journal of Pharmaceutics and Biopharmaceutics. 136. 138–146. 28 indexed citations
15.
Yöyen-Ermiş, Diğdem, Kıvılcım Öztürk, M. Alper Kursunel, et al.. (2018). Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody. Molecular Pharmaceutics. 15(4). 1526–1533. 16 indexed citations
16.
Esendağlı, Güneş, Diğdem Yöyen-Ermiş, Makbule Aydın, et al.. (2017). Impact of repeated abdominal surgery on wound healing and myeloid cell dynamics. Journal of Surgical Research. 223. 188–197. 2 indexed citations
17.
Şahin, Adem, Güneş Esendağlı, Seçil Çaban, et al.. (2017). A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery. Artificial Cells Nanomedicine and Biotechnology. 45(8). 1657–1664. 69 indexed citations
18.
Şahin, Adem, Diğdem Yöyen-Ermiş, Seçil Çaban, et al.. (2017). Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells. Journal of Microencapsulation. 34(7). 659–666. 39 indexed citations
19.
Yöyen-Ermiş, Diğdem, Makbule Aydın, Elif Bilgiç, et al.. (2017). Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis. Immunological Investigations. 46(7). 663–676. 16 indexed citations
20.
Erdoğar, Nazlı, Güneş Esendağlı, Thorbjørn Terndrup Nielsen, et al.. (2017). Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer. Journal of drug targeting. 26(1). 66–74. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ece Tavukçuoğlu Breakdown of academic impact, for papers by Hannah L. O’Mary Breakdown of academic impact, for papers by Nathan A. Rohner Breakdown of academic impact, for papers by Dipak S. Pisal Breakdown of academic impact, for papers by Luisa Vicari Breakdown of academic impact, for papers by Parvin Mahdipoor Breakdown of academic impact, for papers by Christian A. Fernandez Breakdown of academic impact, for papers by Scott Poh Breakdown of academic impact, for papers by Kaiqing Yun Breakdown of academic impact, for papers by Joseph Piscitelli
Rankless by CCL
2026